Medical Xpress - Cardiology
FEBRUARY 27, 2025
Bone marrow transplantation (BMT) can potentially cure sickle cell disease, an inherited and painful blood disorder, but because of its potential drawbacks and costs, patients and caregivers often face the difficult decision of whether to undergo the procedure.
Medical Xpress - Cardiology
APRIL 11, 2024
A drug approved to treat pulmonary arterial hypertension may be effective at managing hypertension and end-organ damage in patients with sickle cell disease, according to a new study published in Lancet Haematology.
HCPLive
SEPTEMBER 8, 2024
A systematic review found a higher prevalence of acute pancreatitis in individuals with the HbSS genotype, though a meta-analysis could not be performed.
HCPLive
APRIL 3, 2024
Our March 2024 month-in-review in hematology features updates to the anemia pipeline, the latest research in sickle cell disease, and the role of SGLT2 inhibition on hematologic outcomes.
Stroke Journal
FEBRUARY 1, 2024
Background:White matter disease is a common phenomenon in patients with sickle cell disease, that has been linked to cognitive impairment. However, there is no standardized approach for quantification of the cerebral disease burden. However, its utility in sickle cell disease has not yet been established.
HCPLive
JULY 14, 2024
A study from the ASH Research Network reports positive antibody response and tolerability after mRNA vaccination in people with sickle cell disease.
HCPLive
DECEMBER 14, 2023
Keli Coleman, MD, discusses findings from her research about the role of pain scores and opioids in predicting hospitalization and return visits in children with sickle cell disease and uncomplicated pain crises.
Expert insights. Personalized for you.
95 
Let's personalize your content